Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Schizophrenia
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Schizophrenia
    Schizophrenia and Bipolar Disorder Share Genetic Roots, Researchers Find - (DGNews)
    Long-Acting Risperidone Shows Benefits in Recent-Onset Schizophrenia: Presented at WCBP - (DGDispatch)
    Injectable Risperidone Superior to Oral Quetiapine in Stable Patients With Schizophrenia Who Need Treatment Switch: Presented at WCBP - (DGDispatch)
    TopAbstracts in Schizophrenia 06/25/2009 - (DGNews)
    TopAbstracts in Schizophrenia 06/11/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Schizophrenia
    • Major Depression and Psychoses: Screening, Accurately Diagnosing, and Properly Managing in Primary Care
    • Consistent Approach and Assessment Tools Aid Screening for Major Depressive Disorder and Psychosis in Primary Care
    • Navigating Differential Diagnosis in Major Depressive Disorder: The Role of the Primary Care Physician
    • Newer Classes Enhance Traditional Antidepressants and Are Preferred First-Line Therapies in Primary Care
    • Optimizing the Management of Schizophrenia: Evidence-Based Methods to Minimize the Burden of Disease in Managed Care

      Webcasts/CME archive

       Recent cases - Schizophrenia
        Localisation Using Mini C-Arm Fluoroscopy of Needles Ingested by a Woman with Schizophrenia: A Case Report
        Schizophrenia Spectrum Disorders in a Nigerian Family: 4 Case Reports
        Massive Pulmonary Emboli Associated with Olanzapine
        Presentation and Course of Brain Metastases from Breast Cancer in a Paranoid-Schizophrenic Patient: A Case Report
        Diabetic Control and Atypical Antipsychotics: A Case Report

        Cases archive
          




        my personal edition > schizophrenia > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Clozapine Treatment Difficult to Maintain Long Term But Highly Effective When Maintained: Presented at CPA

        By Donalee Moulton

        HALIFAX, NS -- November 3, 2003 -- The longest follow-up study of clozapine users has confirmed that the atypical antipsychotic drug offers a highly effective treatment option over time, but long-standing compliance is hard to achieve, according to results presented at the 53rd Annual Meeting of the Canadian Psychiatric Association, held October 30th to November 2nd in Halifax, Nova Scotia, Canada.

        "Clozapine is a difficult medication but extremely effective," said Panth Voruganti, MD, associate professor, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada. "There is significant impact long term but it is difficult to maintain patients long term."

        In this descriptive, cross-sectional study, the researchers conducted clinical assessments in a cohort of schizophrenic outpatients being treated with clozapine and evaluated patients for adverse effects, functional status and quality of life. Participants in the study had been on clozapine, a dibenzodiazepine derivative, for a period of anywhere from five to 13 years.

        Study participants were approximately 78% males with a mean age of 42, a treatment duration of 8 years, and were taking an average daily dose of 431 mg of clozapine.

        The researchers found significant improvement in patients who were on the antipsychotic drug over time as compared to their pre-clozapine days.

        The findings indicated marked functional and behavioural improvement in patients able to maintain a long-term clozapine regimen. Hospitalisation rates decreased noticeably. Study participants had spent a mean of 7.4 days in hospital prior to taking clozapine and 0.99 days post-clozapine. Sixty-two percent were living independently while maintaining a clozapine regimen.

        "We're talking about families who had given up hope," said Dr. Voruganti. "The quality of life is dramatically improved [with clozapine]."

        He recommended that physicians work closely with patients to try and maintain clozapine treatment where possible.


        [Study title: Long-Term Effectiveness of Clozapine Therapy in Treatment – Refractory Schizophrenia: Results of a 5 to 13 Year Follow Up Study. Abstract P1-1]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send